No abstract available
Publication types
-
Editorial
-
Research Support, N.I.H., Extramural
-
Research Support, Non-U.S. Gov't
-
Comment
MeSH terms
-
Adenocarcinoma, Follicular / drug therapy
-
Adenocarcinoma, Follicular / genetics
-
Adenocarcinoma, Follicular / pathology
-
Antineoplastic Agents / adverse effects
-
Antineoplastic Agents / therapeutic use*
-
Benzenesulfonates / therapeutic use
-
Biomarkers, Tumor
-
Carcinoma, Medullary / drug therapy*
-
Carcinoma, Medullary / genetics
-
Carcinoma, Medullary / pathology
-
Carcinoma, Papillary / drug therapy
-
Carcinoma, Papillary / genetics
-
Carcinoma, Papillary / pathology
-
Humans
-
Indoles / adverse effects
-
Indoles / therapeutic use
-
Neoplasm Metastasis / prevention & control
-
Niacinamide / analogs & derivatives
-
Phenylurea Compounds
-
Protein Kinase Inhibitors / adverse effects
-
Protein Kinase Inhibitors / therapeutic use*
-
Pyridines / therapeutic use
-
Pyrroles / adverse effects
-
Pyrroles / therapeutic use
-
Sorafenib
-
Sunitinib
-
Thyroid Neoplasms / drug therapy*
-
Thyroid Neoplasms / genetics
-
Thyroid Neoplasms / pathology
Substances
-
Antineoplastic Agents
-
Benzenesulfonates
-
Biomarkers, Tumor
-
Indoles
-
Phenylurea Compounds
-
Protein Kinase Inhibitors
-
Pyridines
-
Pyrroles
-
Niacinamide
-
Sorafenib
-
Sunitinib